ストックスクリーナーアプリを入手
194.61
2.46%
-4.91
アフターアワーズ：
194.61
前日終値:
$199.52
開ける：
$198.28
24時間の取引高:
783.96K
Relative Volume:
0.91
時価総額：
$12.49B
収益：
$13.84B
当期純損益:
$1.10B
株価収益率:
18.68
EPS:
10.4185
ネットキャッシュフロー:
$1.49B
1週間 パフォーマンス:
-2.96%
1か月 パフォーマンス:
+31.57%
6か月 パフォーマンス:
+68.93%
1年 パフォーマンス:
+34.25%
1日の値動き範囲:
$194.10
$198.93
1週間の範囲:
$191.57
$202.00
52週間の値動き範囲:
$101.00
$202.69
Davita Inc Stock (DVA) Company Profile
Compare DVA vs HCA, THC, FMS, EHC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
194.61 | 12.81B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
404.69 | 93.79B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
191.40 | 16.58B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
22.10 | 11.94B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
104.76 | 10.53B | 6.07B | 793.80M | 464.40M | 5.9914 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-03-06 | 開始されました | Barclays | Equal Weight |
| 2023-08-07 | アップグレード | UBS | Neutral → Buy |
| 2022-11-01 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-10-31 | ダウングレード | UBS | Buy → Neutral |
| 2022-08-19 | 再開されました | UBS | Buy |
| 2022-06-21 | 繰り返されました | BofA Securities | Underperform |
| 2021-09-10 | 開始されました | Cowen | Market Perform |
| 2021-08-12 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2021-03-26 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-01-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-01-24 | アップグレード | Goldman | Neutral → Buy |
| 2019-11-07 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | アップグレード | UBS | Sell → Neutral |
| 2019-01-03 | 開始されました | Deutsche Bank | Buy |
| 2018-12-14 | 開始されました | Barclays | Overweight |
| 2018-11-28 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | 開始されました | UBS | Sell |
| 2018-11-08 | ダウングレード | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | アップグレード | JP Morgan | Underweight → Neutral |
| 2018-01-04 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | アップグレード | Citigroup | Neutral → Buy |
| 2017-12-07 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2017-06-26 | ダウングレード | Jefferies | Buy → Hold |
| 2016-12-13 | ダウングレード | Robert W. Baird | Outperform → Neutral |
すべてを表示
Davita Inc (DVA) 最新ニュース
Best Value Stocks to Buy for May 19th - Yahoo Finance Australia
DaVita stock (US23918K1088): solid Q1 2026, buyback boost and kidney care focus - AD HOC NEWS
Davita chief compliance officer James Hearty sells $2.9m in stock - Investing.com India
DaVita Inc (DVA) Stock Price, Trades & News - GuruFocus
DaVita Sets Bold 2030 Community Care Commitments After Exceeding Prior Five-Year ESG Goals - PR Newswire
Zacks.com featured highlights include DaVita, Antero Resources, PBF Energy and Popular - Yahoo Finance Singapore
DaVita stock (US23918K1088): dialysis provider in focus after strong share price run - AD HOC NEWS
How Investors Are Reacting To DaVita (DVA) Q1 Earnings Beat And Aggressive Share Buybacks - simplywall.st
DaVita Inc (DVA) Stock Up 3.7% but GF Value Says Overvalued -- G - GuruFocus
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita stock (US23918K1088): shares stay near 2026 highs after latest pullback - AD HOC NEWS
DaVita Inc. stock (US23918K1088): strong year-to-date rally despite latest pullback in healthcare se - AD HOC NEWS
DVA Stock Price, Quote & Chart | DAVITA INC (NYSE:DVA) - ChartMill
The 5 Most Interesting Analyst Questions From DaVita’s Q1 Earnings Call - Yahoo Finance
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Does DaVita Insider Equity Move Signal Governance in Russell 1000? - Kalkine Media
DaVita CFO & Treasurer Joel Ackerman Sells 34% Of Holding - simplywall.st
DaVita stock (US23918K1088): TD Cowen raises price target after Q1 earnings - AD HOC NEWS
Insider Sell Alert: David Maughan Sells 20,529 Shares of DaVita Inc (DVA) - GuruFocus
DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DaVita COO David Maughan sells $4.09 million in company stock By Investing.com - Investing.com South Africa
DaVita(DVA.US) Officer Sells US$4.09 Million in Common Stock - Moomoo
What Does DaVita Inc.'s (NYSE:DVA) Share Price Indicate? - 富途牛牛
DaVita stock (US23918K1088): Q1 EPS beat and raised full-year guidance - AD HOC NEWS
What Are Wall Street Analysts' Target Price for DaVita Stock? - Barchart.com
DaVita Stock On Fire: Up 32% With 7-Day Winning Streak - Trefis
DaVita Stock Rockets 32% With 7-Day Winning Streak - Trefis
Here's Why DaVita HealthCare (DVA) is a Strong Momentum Stock - Yahoo Finance
DaVita stock (US23918K1088): TD Cowen raises price target to $201 - AD HOC NEWS
DaVita Stock 6-Day Winning Spree: Stock Climbs 31% - Trefis
Insider Sell: Joel Ackerman Sells 51,471 Shares of DaVita Inc (D - GuruFocus
DaVita (DVA) Leads Goldman Sachs' Buyback Aristocrats Index with Aggressive Share Repurchases - GuruFocus
DaVita HealthCare (DVA) Is Up 30.99% in One Week: What You Should Know - Yahoo Finance
DaVita stock (US23918K1088): Q1 beat and raised guidance lift shares - AD HOC NEWS
DaVita Inc. (DVA) Stock Analysis: Evaluating Growth Potential Amidst a Robust Market Position - DirectorsTalk Interviews
DaVita Inc. stock (US23918K1088): Q1 2026 beat lifts shares after guidance hike - AD HOC NEWS
DaVita Inc. stock (US23918K1088): Q1 2026 earnings and share buybacks lift sentiment - AD HOC NEWS
Evaluating DaVita (DVA) After A Strong Share Price Rally And Mixed Valuation Signals - Yahoo Finance
DaVita Stock 5-Day Winning Spree: Stock Climbs 31% - Trefis
Insider Sell: James Hearty Sells Shares of DaVita Inc (DVA) - GuruFocus
DaVita Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Surging Earnings Estimates Signal Upside for DaVita HealthCare (DVA) Stock - Yahoo Finance
DaVita Inc stock (US23804L1035): Shares surge after Q1 beat and guidance hike - AD HOC NEWS
Here's Why DaVita HealthCare (DVA) is a Strong Value Stock - Yahoo Finance
DaVita Inc. Stock (US23918K1088): Analyst Upgrade and Earnings Outlook Drive Investor Interest - AD HOC NEWS
DaVita (DVA) Sees 19.6% Surge, Reaches $187.75 - GuruFocus
DaVita (DVA) Revenue Growth Drives Deutsche Bank Upgrade to Buy Rating - Insider Monkey
DaVita (DVA) Is Up 27.6% After Boosting 2026 EPS Guidance On Strong Q1 Results - Yahoo Finance
UBS Adjusts Price Target on DaVita to $235 From $190, Maintains Buy Rating - marketscreener.com
Should Value Investors Buy DaVita (DVA) Stock? - Yahoo Finance
DaVita: Improved Volumes And Tech In Focus (Rating Upgrade) (NYSE:DVA) - Seeking Alpha
Davita Inc (DVA) 財務データ
収益
当期純利益
現金流量
EPS
0.54%
大文字化:
|
ボリューム (24 時間):